Tag Archives: Acute

Sprycel (dasatinib) Tablets Now Approved in Combination with Chemotherapy in Certain Pediatric Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Print this page PRINCETON, N.J.–(BUSINESS WIRE)–Bristol-Myers Squibb Company (NYSE:BMY) today announced the U.S. Food and Drug Administration (FDA) has expanded the indication for Sprycel ® (dasatinib) tablets to include the treatment of pediatric patients one year of age and older with newly diagnosed Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) in combination with chemotherapy.1 Sprycel… Read More »

Severe Rhabdomyolysis in a Patient With Acute Influenza Infection

January 03, 2019 This article originally appeared here. Share this content: Rhabdomyolysis is characterized by breakdown of muscle tissue A recently published case report describes the case of a 29-year-old male patient with influenza-induced rhabdomyolysis and highlights the need to assess creatinine kinase (CK) levels of patients hospitalized with influenza. The patient, who had a… Read More »

FDA Approves Daurismo (glasdegib) for Patients with Acute Myeloid Leukemia

FDA Approves Daurismo (glasdegib) for Patients with Acute Myeloid Leukemia Print this page November 21, 2018 — The U.S. Food and Drug Administration today approved Daurismo (glasdegib) tablets to be used in combination with low-dose cytarabine (LDAC), a type of chemotherapy, for the treatment of newly-diagnosed acute myeloid leukemia (AML) in adults who are 75… Read More »

Acute flaccid myelitis

Centers for Disease Control and Prevention website. Acute flaccid myelitis. www.cdc.gov/acute-flaccid-myelitis/index.html. Updated October 22, 2018. Accessed October 30, 2018. Genetic and Rare Diseases Information Center website. Acute flaccid myelitis. US Department of Health and Human Services. National Institute of Health. rarediseases.info.nih.gov/diseases/13142/acute-flaccid-myelitis. Updated October 9, 2018. Accessed October 30, 2018 Messacar K, Modlin JF, Abzug MJ.… Read More »